EXCExelon

$41.76-0.53% 1Y

Is the price fair?

Fair

Neither cheap nor expensive: nothing decisive, though cheap vs its sector.

1 good, 1 neutral, 1 without data
Vs its own P/E rangemid-range for this companyderived

In its normal range: P/E 15.9 vs a 12.1 median over 30 quarters (+32% vs median).

Vs sector (EV/EBIT)18.6×derived · Mar 31, 2026

Sector median 22.4× across 56 covered peers. EV/EBIT counts debt as part of the price, so a cash-rich and a borrowed company can be compared on the same footing.

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

What EXC's price assumes

Exelon has no trailing P/E on file, so the price is measured against sales instead: 1.89× revenue.

1.89

Price / sales · no trailing P/E on file: measured against sales instead

Price / book
1.60

Price / book · today's price, trailing year to Mar 31, 2026

EV / sales
3.91

EV / sales

Details›
Price / booktoday's price, trailing year to Mar 31, 2026
1.60
EV / EBITtoday's price, trailing year to Mar 31, 2026
18.6
EV / salestoday's price, trailing year to Mar 31, 2026
3.91
Market capitalisation
$46.9B

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.